Abeona Therapeutics Inc

09/16/2026

Access to specialized care is an important part of the treatment journey for individuals living with recessive dystrophic epidermolysis bullosa (RDEB).

Abeona announces the activation of the newest Qualified Treatment Center for the administration of our autologous cell-based gene therapy.

Read more: https://bit.ly/4Aido84

08/27/2026

Together with patients, families, caregivers and advocates, Abeona team members participated in DASH4DEBRA in support of the epidermolysis bullosa (EB) community.

Thank you to debra of America for bringing people together to raise awareness and support for those affected by EB.

07/30/2026

We were thrilled to be on site at the 2026 debra of America Care Conference in Los Angeles!

This incredible gathering brought together individuals and families living with epidermolysis bullosa (EB) alongside clinicians and researchers, all united in advancing care, support and innovation for the EB community.

06/19/2026

Caring for someone with an ultra-rare condition like recessive dystrophic epidermolysis bullosa ( ) comes with daily challenges. In this BioSpace Denatured episode, Abeona CEO & Director Vishwas Seshadri shares how new gene and cell therapies could help change what’s possible for patients and families.

Listen here:

In this episode of Denatured, you’ll hear from Mark Lowdell, CSO & co-founder at INmuneBio Inc. and Vishwas Seshadri, CEO & director at Abeona Therapeutics. We explore how recessive dystrophic epidermolysis bullosa has become a defining case study for gene and cell therapy and what this ultra‑ra...

04/17/2026

We were so excited to jump back in and Plunge for Elodie this year! On April 8, our Cleveland team hosted a dunk tank to support EB Research Partnership and the amazing epidermolysis bullosa (EB) community.